關閉
Philosophy & History

About SCI

SCI Pharmtech Inc., founded by Switzerland-based Siegfried Ltd. in 1987, is now a public company listed at Taiwan Stock Exchange.
Since 1989, SCI has satisfied worldwide customers with quality and cost-effective APIs, advanced intermediates, and custom products.
Our fully equipped research laboratories, pilot and production plants and experienced staff ensure timely development and cost effective production.
We work with pharmaceutical and specialty companies worldwide to develop key intermediates, APIs and custom products.
Our facility is FDA,EDQM and Taiwan TFDA inspected, designed for multi-purpose, full-scale manufacturing.
 

Company Mission

To be a well recognized partner for pharmaceutical products and chemical services by creating sustainable solutions to the industry.

Corporate Vision

For the health of human being, we contribute.

Philosophy & History
Sustainability
Philosophy & History
Credibility
Philosophy & History
Innovation
Philosophy & History
永續Sustainability
Philosophy & History
信賴Credibility
Philosophy & History
創新Innovation

SCI History

  • 1980

    • Sep. 1987 Established by Siegfried Group (Switzerland) as an intermdeiate provider in Asia. Siegfried owned 80%
    • Dec. 1989 Production commenced
  • 1990

    • Apr. 1996 Siegfried Group acquired 100% of shares
    • Nov. 1999 ISO 14001 certified
  • 2000

    • Apr. 2001 Mercuries Group acquired 80% of shares
    • Oct. 2001 ISO 9001 certified
    • Apr. 2002 Company name changed to “SCI Pharmtech Inc” 35 products commercialized
    • Jan. 2004 Listed on Taiwan stock exchange market
    • Jun. 2004 Inspected by Taiwan health authorities
    • Nov. 2005 Inspected by US FDA 1ST
    • Jun. 2008 Established Nanjing SCI Pharmtech Ltd in Nanjing, China
  • 2010

    • May 2010 OHSAS 18001 certified
    • Nov. 2010 Inspected by EDQM 1ST
    • Apr. 2012 Inspected by US FDA 2ND
    • Sep. 2012 Inspected by KFDA 1ST
    • Mar. 2013 Liquidated Nanjing SCI Pharmtech Ltd in Nanjing, China
    • Jun. 2013 Established Yushan Pharmaceuticals, Inc.
    • Dec. 2014 Inspected by US FDA 3RD
    • Nov. 2016 Inspected by EDQM 2ND
    • Sep. 2017 Inspected by US FDA 4TH
    • Nov. 2017 Inspected by PMDA 1ST
    • Oct. 2019 Rated perfect bonded warehouse by Taiwan customs, and keeps maintaining the status
    • Nov. 2019 Inspected by US FDA 5TH
  • 2020

    • April. 2020 Visited by President Tsai, who instructed the formation of Pharmaceuticals Manufacturing Team